In corporate news, Gsk Plc (GSK.LN) climbed over +5% after the drugmaker agreed to pay up to $2.2 billion to settle U.S. court cases related to its heartburn treatment, Zantac. Italy’s Industrial ...
Some results have been hidden because they may be inaccessible to you